Therapeutic formulation for reduced drug side effects
The present invention provides drug therapy formulations for reducing the side effects associated with a therapeutic. In some embodiments, the present invention provides a reduction in sleep- and diet-related side effects associated with a therapeutic.
1. A pharmaceutical composition consisting of dexamphetamine nanoparticles, wherein the dexamphetamine nanoparticles have a mean diameter of up to 50 nm, and guanfacine.
2. The pharmaceutical composition of 1 , wherein the dexamphetamine nanoparticles have a mean diameter of up to 25 nm.
3. A pharmaceutical composition consisting of:
a. a component formulated for rapid release consisting of dexamphetamine nanoparticles wherein the dexamphetamine nanoparticles have a mean diameter of up to 50 nm; and
b. component formulated for delayed release consisting of guanfacine.
4. The pharmaceutical composition of 3 , wherein the dexamphetamine nanoparticles have a mean diameter of up 25 nm.
5. A pharmaceutical composition consisting of:
a. a component formulated for rapid release consisting of amphetamine nanoparticles wherein the amphetamine nanoparticles consist of levoamphetamine and dexamphetamine, and the amphetamine nanoparticles have a mean diameter of up to 50 nm; and
b. a component formulated for delayed release consisting of guanfacine.
6. The pharmaceutical composition of claim 5 , wherein said amphetamine nanoparticles have a mean diameter of up to 25 nm.